Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era

Department

Research

Document Type

Article

Publication Title

Pediatrics

Abstract

OBJECTIVES: To study the epidemiology of acute otitis media (AOM), especially the otitis-prone condition, during the pneumococcal conjugate vaccines 7 and 13 era. METHODS: Six hundred and fifteen children were prospectively managed from 6 to 36 months of life during a 10-year time frame (June 2006-June 2016). All clinical diagnoses of AOM were confirmed by tympanocentesis and bacterial culture of middle ear fluid. RESULTS: By 1 year of age, 23% of the children experienced ≥1 episode of AOM; by 3 years of age, 60% had ≥1 episodes of AOM, and 24% had ≥3 episodes. The peak incidence occurred at 6 to 12 months of life. Multivariable analysis of demographic and environmental data revealed a significantly increased risk of AOM associated with male sex, non-Hispanic white race, family history of recurrent AOM, day care attendance, and early occurrence of AOM. Risk factors for stringently defined (tympanocentesis-confirmed) otitis proneness, in which children suffered at least 3 episodes of AOM in a 6-month period or at least 4 within a year, were male sex, day care attendance, and family history of AOM, whereas breastfeeding in the first 6 months of life was protective. Stringently defined otitis prone children were also likely to experience their first AOM episode at a younger age. The proportion of , and causing AOM had dynamic changes during the past decade. CONCLUSIONS: We conclude that the epidemiology but not the risk factors for AOM have undergone substantial changes since the introduction of pneumococcal conjugate vaccines.

DOI

10.1542/peds.2017-0181

Volume

140

Issue

3

Publication Date

9-1-2017

Medical Subject Headings

Acute Disease; Child, Preschool; Female; Humans; Incidence; Infant; Male; Otitis Media (epidemiology, immunology); Pneumococcal Infections (prevention & control); Pneumococcal Vaccines (administration & dosage); Prospective Studies; Streptococcus pneumoniae (immunology); Vaccines, Conjugate (administration & dosage)

PubMed ID

28784702

Link to Full Text

Share

COinS